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Reduction of plasma triglycerides by diet in subjects with
chronic renal failure
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Department of Medicine, Stanford University School of Medicine and Veterans A dminist ration Hospital, Palo Alto, Califirnia
Reduction of plasma triglycerides by diet in subjects with chronic
renal failure. The response of plasma triglyceride levels to changes
in the composition of meal formula diets was studied in 12 subjects
who had moderate to severe chronic renal failure. Fasting hyper-
triglyceridemia (> 150 mg/l00 ml) was present in seven of 12
subjects. Fasting plasma triglyceride levels decreased in all subjects
in response to a reduction in the proportion of carbohydrate (from
50 to 35% of total daily calories) and an increase in the poly-
unsaturated to saturated fat ratio (from 0.2 to 2.0) in an isocaloric
diet. Fasting plasma cholesterol and postprandial triglyceride lev-
els were unchanged. Both the triglyceride production rate and the
insulin response were significantly lower on a diet lower in car-
bohydrate and higher in polyunsaturated fat. These data indicate
that hypertriglyceridemia occurs in subjects with moderate to se-
vere chronic renal failure, and that dietary modification promptly
reduces triglyceride levels over an 11 day period. A long term study
on a dietary program incorporating these changes is indicated to
determine whether this effect is sustained.
Deminution des triglycerides plasmatiques chez les sujets en in-
suffisance rénale chronique. La réponse des triglycerides plasma-
tiques aux modifications de Ia composition des regimes alimen-
taires a été Ctudiée chez 12 sujets atteints d'insuffisance rénale
chronique modérée ou sévère. Une hypertriglycéridémie a jeun
(ISO mg/lOO ml) existait chez sept parmi les 12 sujets. Les concen-
trations plasmatiques des triglycerides a jeun ont diminuC chez
tous les sujets en réponse a Ia diminution de Ia proportion
d'hydrates de carbone (de 50% a 35% du total des calories) et
a l'augmentation du rapport des acides gras non saturés aux acides
gras saturés (de 0.2 a 2.0) dans un régime iso-calorique. Le choles-
térol plasmatique a jeun et les triglycerides post-prandiaux n'ont
pas été modifies. La production de tryglycérides et Ia réponse a
l'insuline ont été signiflcativement diminuees au cours du regime
pauvre en hydrates de carbone. Ces résultats indiquent que
l'hypertriglyceridémie survient ches des sujets atteints d'insuffis-
ance rénale chronique modérCe on sévCre et que les modifications
diCtetiques rCduisent rapidement l'hypertriglycCridémie sur une
période de 11 jours. Une étude de longue durée d'un programme
diététique utilisant ces données est utile pour savoir si l'effet obtenu
est durable.
Elevated levels of plasma triglycerides have been
reported in both dialyzed and undialyzed non-
nephrotic patients with end-stage renal failure [1—7].
However, very little information is available con-
cerning the levels of triglycerides in patients during
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the often long period of progression to end-stage
renal failure. Such information could be particularly
important because during that period patients are
often placed on diets relatively low in protein. As a
consequence they tend to eat increased amounts of
carbohydrates and fats. A moderate increase in car-
bohydrate intake has been shown to elevate plasma
triglycerides in subjects with normal renal function
[8], and may account for similar elevations in patients
with chronic renal failure.
The development of hypertriglyceridemia in
patients with chronic renal failure is particularly rele-
vant in view of the evidence that myocardial in-
farction, refractory congestive heart failure and Ce-
rebrovascular accidents are more common in patients
with end-stage renal failure than in normal or hyper-
tensive populations [9—12]. Recognition that cardio-
vascular disease is the leading cause of death in
patients on chronic hemodialysis has heightened con-
cern for potentially reversible attendant risk factors
[13, 14]. In this regard, recent awareness of hyper-
triglyceridemia as a possible independent risk factor
for the development of atherosclerotic heart disease is
of critical importance. Three kinds of evidence link
hypertriglyceridemia to the development of athe-
rosclerotic heart disease. Earlier studies simply in-
dicated that hypertriglyceridemia was commonly
found in patients with atherosclerotic heart disease
[15]. More recently, a nine—year prospective study
demonstrated that elevated fasting plasma triglyce-
rides were a risk factor for atherosclerotic heart dis-
ease independent of plasma cholesterol [161. Finally,
these observations have been supported by the dem-
onstrated association between hypertriglyceridemia
and angiographically documented coronary artery
disease [17]. At the same time, considerable evidence
exists which argues that hypertriglyceridemiaperse is
not an independent risk factor for the development of
atherosclerotic heart disease [18—20]. However, as
Brunzell and co-workers have pointed out, the situa-
Reduction of plasma triglycerides in uremia 55
tion might be very different when the hypertriglyceri-
demia exists in conjunction with other risk factors
such as diabetes or renal failure [21], and in these
situations it is certainly possible that hypertriglyceri-
demia accentuates the risk of developing athe-
rosclerotic heart disease. If hypertriglyceridemia oc-
curs early in the course of renal failure, early
intervention may help avoid chronic elevations of
plasma triglycerides, which could predispose patients
to atherosclerosis. We undertook this study in an
attempt to address both of these issues. Our approach
has been to study patients prior to the development
of end-stage renal failure to a) define the levels of
triglycerides seen during moderate to severe chronic
renal failure, and b) determine whether the triglyce-
ride levels in these patients would respond to modifi-
cation simply by dietary manipulation.
Methods
Patients. Twelve non-nephrotic subjects with
chronic renal failure were selected from the out-
patient renal clinics of Stanford University Medical
Center and the Palo Alto Veterans Administration
Hospital. None of the patients were on insulin, pred-
nisone, androgenic steroids or lipid-lowering agents
prior to study. All had documented creatinine clear-
ance determinations of less than 50 mI/mm and he-
matocrit values of 25% or greater at the initiation of
the study. Selection criteria excluded patients with
recent myocardial infarction or cerebrovascular acci-
dent, uncontrolled hypertension or serum albumin
less than 3.0 g/100 ml. Selection was made without
regard to a history of lipid abnormalities.
Protocol. Subjects were admitted to the Stanford
General Clinical Research Center and assigned to
one of tw.o isocaloric formula (liquid) diets. [Formula
diets were used to facilitate controlled metabolic
studies. However, the contents are readily convertible
into a practical meal-planning program. Essentially
this involves manipulating the proportions of total
daily calories supplied by carboh.ydrates and fats, the
polyunsaturated to saturated fat ratio, and the choles-
terol content. The proportion of total calories sup-
plied as protein is maintained at 10%. (See Appen-
dix.)] Both diets contained 35 calories/kg of body wt
per day and were given as one-fifth of total calories at
8 AM, two-fifths at noon and two-fifths at 5 PM.
Weights were stable throughout the study.
One diet, the "conventional" diet, was designed to
simulate the diet most subjects were considered to be
eating at home. It contained 10% of total calories as
protein, 50% as carbohydrates and 40% as fat. Cho-
lesterol content was 600 mg/day. Polyunsaturated to
saturated fat ratio was 0.2. The second diet, a "low
carbohydrate" diet, also contained 10% of total calo-
ries as protein. However, the carbohydrate content
was reduced from 50 to 35%. To maintain caloric
balance, fat content was increased from 40 to 55%,
but the type of fat was changed to yield a poly-
unsaturated to saturated fat ratio of 2.0. In addition,
the cholesterol content was reduced to 300 mg/day.
Thus, the "low carbohydrate" diet was, in fact, low in
both carbohydrate and cholesterol and relatively high
in polyunsaturated fat. For the sake of brevity, it will
hereafter be referred to as the "low carbohydrate"
diet. Contents of sucrose, sodium, and potassium
were identical in both diets.
A single blind cross—over design was used. That is,
subject I began on the conventional diet. After the
11—day period, he switched to the "low carbohy-
drate" diet. Subject 2 began on the "low carbohy-
drate" diet, then switched to the conventional diet,
and so on. After three days on the conventional diet,
an oral glucose tolerance test was done [22]. The
sequence of tests that occurred during each 11—day
period was as follows: 1) fasting glucose, insulin,
triglyceride, cholesterol, free fatty acid, and growth
hormone levels were obtained on days 4, 7, 10 and 11;
2) a meal tolerance test was performed on day 7,
during which plasma glucose, insulin and triglyceride
levels were measured in response to the lunch meal.
For this purpose, a blood sample was taken just prior
to ingestion of the noon meal, and again at 1, 2 and 3
PM; 3) determination of triglyceride turnover rate
was performed on day 11. An injection of 300tCi of
tritium-labeled glycerol was given intravenously at 8
AM. Subjects received one-twelfth of the day's for-
mula at 2 PM and 5 PM to maintain constant plasma
triglyceride levels. Blood samples were drawn at 10
AM, 11 AM, noon, 2, 5 and 8 PM for measurement
of the resultant triglyceride specific activity. The
triglyceride turnover rate was then calculated from
the triglyceride specific activity time—curve by a pre-
viously described technique [23]. Since these studies
were carried out under steady state conditions, turn-
over rate = removal rate = production rate. There-
fore, hereafter triglyceride turnover rate will be re-
ferred to as triglyceride production rate.
Analytical Methods. Blood for glucose, triglyce-
rides and cholesterol determinations was withdrawn
into tubes containing disodium EDTA; blood for free
fatty acids was withdrawn into tubes with sodium
heparin. Blood specimens were separated immedi-
ately by ultracentrifugation and all samples stored at
4°C. Plasma glucose concentrations were measured
by an oxygen rate modification of the glucose oxidase
method adapted for the Beckman Glucose Analyzer
[24]. Immunoreactive insulin and growth hormone
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levels were measured by a modification of the method
of Desbuquois and Aurbach [25]. Plasma triglyceride
and cholesterol levels were determined with an auto-
analyzer (Technicon, methods N—78 and N—24a, re-
spectively). Free fatty acids were measured by the
method of Antonis [26J. Ideal weights were deter-
mined according to the 1960 Metropolitan Life Ta-
bles.
Statistical methods employed included Spearman's
rank correlation coefficient and Pearson's product-
moment correlation coefficient, a cross—over design
analysis of ratios for comparison of responses on the
two diets and of areas under the insulin response
curves, and an analysis of variance F test.
Results
The study group was composed of ten males and
two females with mean age (± standard error, SEM) of
42 ÷ 3 years (range, 25 to 60). The mean creatinine
clearance determination, corrected for body surface
area, was 19 3 ml/min (range, 7 to 36). The mean
body weight was 78.9 kg (range, 55.3 to 102.5). The
mean relative weight for the group was 113%. Two
subjects had relative weights above 120%, but both
had fasting triglyceride levels well within one stand-
ard deviation of the mean. Three subjects had ab-
normal values for the glucose tolerance tests by the
revised criteria of Fajans and Conn [22, 27].
Figure 1 depicts the effect of the two diets on
fasting plasma levels of triglycerides, cholesterol, glu-
cose, and insulin for the 12 subjects. Mean values
were calculated from an average of 3 to 4 measure-
ments for each subject. Mean (± SEM) fasting plasma
triglyceride levels for the group on the conventional
diet were 256 + 57 mg/100 ml. Seven of the 12
subjects on the conventional diet had fasting values
above 150 mg/lOO ml. Six of 12 were over 200
mg/lOO ml. Fasting triglyceride levels fell in each
subject on the "low carbohydrate" diet to a mean of
169 36 mg/l00 ml, This difference was significant
(P < 0.001). Fasting values for cholesterol, glucose
and insulin were similar on the two diets. Free fatty
acid and growth hormone levels, not shown, were
also similar on the two diets. Thus, the "low carbohy-
drate" diet led to a fall in fasting triglyceride levels.
The concomitant increase in fat did not lead to a rise
in fasting cholesterol, presumably because of the in-
creased polyunsaturated to saturated fat ratio and the
decrease in dietary cholesterol. No correlation by
either Spearman's or Pearson's coefficient was found
between the following variables: a) either the creati-
nine clearance or the degree of azotemia and fasting
triglyceride levels, b) fasting triglycerides and choles-
terol levels, c) either age or relative weights and fas-
ting triglyceride levels.
Since the "low carbohydrate" diet contained 15%
more fat than the conventional diet, it might be ex-
pected to increase postprandial fat levels, and, there-
fore, to diminish the benefits achieved by decreasing
fasting triglyceride levels. However, no such elevation
was observed, as illustrated in Figure 2. This graph
shows the effect of the "low carbohydrate" diet on
postprandial triglyceride levels. Fasting values for
that day are also shown. Mean values for the group
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Fig. 1. Effect ofdiet on fasting plasma levels of triglycerides, choles-
terol, glucose and insulin (mean SEM). Triglyceride levels were















• = Conventional diet
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Fig. 2. Effect of low carbohydrate diet on fasting and postprandial
triglyceride levels (mean + SEM for the group). Fasting values for
that day are also shown.
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(± SEM) are shown before breakfast and at noon, 1, 2
and 3 PM. Noon values were obtained just prior to
meal ingestion. Fasting triglyceride values that day
were significantly lower on the "low carbohydrate"
diet. Although postprandial triglyceride levels tended
to increase more on the "low carbohydrate" diet, at
no time did they exceed the triglyceride levels at-
tained on the conventional diet. (All values for a
given subject were determined during the same as-
say.) In fact, postprandial triglyceride levels re-
mained lower at each time point on the "low car-
bohydrate" diet, but the differences were no longer
significant.
Thus, by decreasing the carbohydrate intake, we
achieved a fall in fasting triglycerides without a con-
comitant increase in cholesterol or postprandial
triglyceride levels. In order to help elucidate the
mechanism of the decrease in fasting plasma triglyce-
ride levels, we determined triglyceride production
rates on both diets. Results are plotted in Figure 3,
along with a curve describing the relationship be-
tween plasma triglyceride concentration and produc-
tion rate in subjects with normal renal function stud-
ied previously by Olefsky, Farquhar, and Reaven
[23]. Several points can be made from these data. In
the first place, plasma triglyceride levels directly cor-
related with triglyceride production rates (r = 0.78, P
< 0.001). Second, the fall in triglyceride concentra-
tion that occurred in each patient was associated with
a fall in triglyceride production rate (P < 0.001).
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level were associated with decreases in triglyceride
production rate does not mean that the initial hyper-
triglyceridemia was due to greater than normal rates
of triglyceride production in these subjects. Indeed,
inspection of Figure 3 suggests the converse, i.e.,
most experimental points fall below the curve de-
scribing the relationship between plasma triglyceride
level and production rate previously observed in nor-
mal individuals. In other words, patients with chronic
renal failure had a higher triglyceride level than did
normal subjects at any given triglyceride production
rate. In order to analyze this relationship more thor-
oughly, we compared the observed ratio of plasma
triglyceride concentration to turnover rate in our
male patients (10 of 12 subjects) with the ratio ob-
served in male patients previously described by
Olefsky, Farquhar, and Reaven [23]. In nine of our
ten male subjects, the observed ratio was higher than
that previously observed (P < 0.001 analysis of vari-
ance F test), indicating that these patients remove
very low-density lipoproteins (VLDL) from plasma
less efficiently than do normal subjects.
Previous studies in subjects with normal renal fail-
ure have demonstrated that the triglyceride response
to a given diet is closely related to the evoked insulin
response [28, 29]. To determine whether this was the
case in our patient population, we examined the in-
sulin response to meals in our subjects on both diets.
Results seen in Figure 4 show that the insulin re-
sponse (area under the curve) was less on the "low
carbohydrate" diet in II of 12 subjects, and the mean
insulin response was significantly lower (P < 0.05).
Discussion
The results of our studies indicate that hypertrigly-
ceridemia can develop in patients with renal disease
prior to the occurrence of end-stage renal failure. The
mean fasting plasma triglyceride level in these sub-
jects on the conventional diet was 256 mg/lOO ml;
seven of the 12 subjects had plasma triglyceride levels
greater than 150 mg/lOO ml, and six of the subjects
had triglyceride levels greater than 200 mg/100 ml.
These values are certainly greater than might be an-
ticipated in a comparable population in the absence
of renal disease [30], and suggest that a prolonged
period of hypertriglyceridemia occurs in the natural
history of patients with chronic renal disease. How-
ever, these results also indicate that a relatively mod-
erate decrease in dietary carbohydrate intake (and
associated increase in polyunsaturated fat) can lead
to a significant fall in plasma triglyceride levels in all
subjects. Furthermore, this effect was produced with-
out a concomitant increase in either postprandial






Fig. 3. Relationship between triglyceride production rate and
triglyceride concentration for subjects on each diet. Hyperbolic
curve portrays this relationship as seen in a group of normals
previously studied in our center.
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case it appears that the degree of fall in fasting
plasma triglyceride levels on the "low carbohydrate"
diet more than compensated for the relatively greater
increase in postprandial triglyceride levels, thus lead-
ing to triglyceride levels which were always lower
than those on the conventional diet. Furthermore,
the fall in postprandial plasma triglycerides contin-
ued over the period of observation. There is no rea-
son to suspect that the levels would increase prior to
ingestion of the dinner meal.
The lack of a rise in plasma cholesterol levels was
most likely due to the fact that the cholesterol intake
was decreased and the polyunsaturated to saturated
fat ratio increased in the "low carbohydrate" diet.
We feel that the 15% decrease in carbohydrate intake
alone could account for the fall in plasma triglyceride
levels, since previous studies of patients with normal
renal function have shown that similar modifications
of carbohydrate intake have had a comparable im-
pact on plasma triglyceride levels [8]. On the other
hand, this does not mean that the triglyceride-lower-
ing effect of the diet was totally due to low carbohy-
drate, since others have shown that substituting poly-
unsaturated fat for saturated fat in the diet also
lowered triglycerides (TG), and that this effect may
be accomplished by increasing VLDL-TG removal
rate [31, 32]. Thus, it is difficult to separate out effects
of carbohydrate and fat. To conclusively demonstrate
the role of carbohydrate alone in the production of
hypertriglyceridemia would require a third dietary
period involving 50% carbohydrate, 40% fat, 10%
protein, 300 mg cholesterol and a polyunsaturated to
saturated fat ratio of 2. However, our goal was not to
define the discrete dietary variable responsible for
hypertriglyceridemia in these subjects. Rather we
have attempted to determine whether plasma
triglyceride levels in these subjects would respond to
relatively simple dietary modification.
The fall in fasting triglyceride level produced by the
"low carbohydrate" diet was associated with a de-
crease in triglyceride production rate, possibly sec-
ondary to a decrease in the insulin response elicited
by that diet. However, this does not necessarily imply
that greater than normal production rates are the
cause of hypertriglyceridemia in patients with chronic
renal failure. In fact, the opposite generalization
seems more likely. Thus, the data in Figure 3 indicate
that the relationship between plasma triglyceride con-
centration and production in patients with renal fail-
ure differs somewhat from that described in subjects
with normal renal function. In general, triglyceride
levels appear to be higher than normal in patients
with renal failure at a given triglyceride production
rate, suggesting that a defect in VLDL removal is
o Low carbohydrate diet
Fig. 4. Insulin responses of individual subjects to noon meal. Total
insulin area expresses area under the curve calculation. Bars depict
group mean on each diet.
responsible for the hypertriglyceridemia. Similar data
have already been reported by Cattran and co-work-
ers [7], who compared the relationship between
plasma triglyceride levels and production rates ob-
served in a group of patients with end-stage renal
failure to the relationship between these two variables
observed by Nikkilä and Kekki [33] on a group of
normal subjects. They also noted that patients with
chronic renal failure had a greater triglyceride level
for any given triglyceride production rate than did
the normal subjects, and they postulated that a defect
in triglyceride removal was responsible for the devel-
opment of hypertriglyceridemia. The notion that
VLDL removal defect is present in patients with
uremia is also supported by the work of several
groups who have described a decrease in plasma post-
heparin lipolytic activity in uremic subjects [2, 34,
35]. On the other hand, it should be remembered that
measurements of plasma postheparin lipolytic activ-
ity provide only an indirect measurement of VLDL
removal rate. Furthermore, it must also be empha-
sized that neither we nor Cattran et al [7] studied
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comparing the relationship between triglyceride con-
centration and production rates in patients with renal
failure to the relationship that existed between these
two variables in normal subjects studied at some
other time. Furthermore, a question has been raised
as to the validity of comparing results of plasma
triglyceride turnover data in subjects on different
diets [36]. In this regard, previous work in our labo-
ratory on several different diets demonstrates no sys-
tematic variation from the normal relationship between
triglyceride concentration and turnover (or produc-
tion) rate utilizing the currently employed technique
[28, 37]. Finally, it is also clear from Figure 3 that
heterogeneity exists in the relationship between
triglyceride level and production rate in the patients
we studied, and that this relationship appeared to be
completely normal in some patients with renal fail-
ure. Thus, although we believe that the current data
are most consistent with the hypothesis that a defect
in VLDL removal is the major cause of hypertrigly-
ceridemia in patients with chronic renal failure, we
feel that final judgment should await the evaluation
of triglyceride kinetics in a larger number of subjects.
On the other hand, even if a defect in VLDL re-
moval will eventually prove to be the sole defect
responsible for hypertriglyceridemia in patients with
renal failure, it does not mean that efforts aimed at
decreasing VLDL production rate will not be thera-
peutically useful. Thus, the data in Figure 3 clearly
indicate that a significant direct correlation exists
between triglyceride production rate and concentra-
tion in uremic subjects, e.g., the higher the produc-
tion rate, the higher the concentration. This may be
especially pertinent in view of the fact that plasma
cholesterol levels, an established risk factor for athe-
rosclerosis in nonuremic subjects, are generally nor-
mal or only modestly elevated in subjects with
chronic renal failure. Since subjects with chronic
renal failure have elevated levels of plasma triglyce-
rides, and since hypertriglyceridemia may be a risk
factor for atherosclerosis in subjects with normal
renal function, hypertriglyceridemia may be partially
responsible for the increased risk of developing athe-
rosclerotic heart disease in these subjects. In fact,
plasma triglycerides may play a greater role in these
subjects than in those with normal kidney function
[21]. For this reason it seems reasonable to attempt to
lower triglyceride production rates, and consequently
triglyceride levels, in these patients. Our results dem-
onstrate that this can be accomplished by dietary
modification. It is possible that manipulation of the
polyunsaturated to saturated fat ratio alone would
yield similar results to those achieved in this study.
However, since high carbohydrate intake is known to
cause hypertriglyceridemia, we recommend avoid-
ance of a high carbohydrate intake in conjunction
with lowered cholesterol intake and increased poly-
unsaturated fat. Another possible approach, the ad-
ministration of lipid-lowering drugs, e.g., clofibrate,
has been recently shown to be associated with serious
complications [38, 39]. In view of these problems we
would suggest that dietary modification, which does
not on initial study appear to be associated with
attendant risks, may offer an approach which is both
safer and more physiologic. Obviously, further study
is required to determine whether this approach can
safely produce sustained reduction over a significant
length of time. In addition, studies are now in prog-
ress to determine whether dietary modification will be
equally effective in subjects already on chronic hemo-
dialysis. A long-term follow-up study on nonformula
meals with the recommended dietary prescription is
also under consideration. The results of these in-
vestigations should lend further insight into the po-
tential application of dietary changes to control of
hypertriglyceridemia in patients with chronic renal
failure.
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Appendix
A. Low carbohydrate, low cholesterol, high poly-
unsaturated fat diet
1. Proportion of constituents:
35% carbohydrate
10% protein
55% fat, polyunsaturated to saturated fat ra-
tio, 2.0
2. Amounts (gm) for 70 Kg reference man:
214 gm of carbohydrate
61 gm of protein
150 gm of fat (inclades 300 mg cholesterol)
2450 calories
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B. Sample menu:
Breakfast
1 cup dry cereal/i tsp sugar
1/2 cup Mocha Mixa
1/2 cup nonfat milk
2 slices toast
4 tsp. margarin&'
1/2 cup orange juice
coffee with 1 tsp. sugar and





green salad with 1-1/2 tbsp. dressing
coffee with 1 oz. Mocha Mix and
I tsp. sugar
a Non-dairy creamer containing polyunsaturated fat
Soft tub type using corn oil or safflower oil base
Poultry, veal, fish; lean cuts of beef, lamb, ham, pork
Reprint requests to Dr. Mary L. Sanfelippo, Veterans Administra-
tion Hospital (1l1-R), 3801 Miranda Avenue, Palo Alto, California
94304. USA.
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